Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers

NRG1 rearrangements are oncogenic drivers that are enriched in invasive mucinous adenocarcinomas (IMAs) of the lung. The oncoprotein binds ERBB3-ERBB2 heterodimers and activates downstream signaling, supporting a therapeutic paradigm of ERBB3/ERBB2 inhibition. As proof of concept, a durable response...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Discov
Päätekijät: Drilon, Alexander, Somwar, Romel, Mangatt, Biju P., Edgren, Henrik, Desmeules, Patrice, Ruusulehto, Anja, Smith, Roger S., Delasos, Lukas, Vojnic, Morana, Plodkowski, Andrew J., Sabari, Joshua, Ng, Kenneth, Montecalvo, Joseph, Chang, Jason, Tai, Huichun, Lockwood, William W., Martinez, Victor, Riely, Gregory J., Rudin, Charles M., Kris, Mark G., Arcila, Maria E., Matheny, Christopher, Benayed, Ryma, Rekhtman, Natasha, Ladanyi, Marc, Ganji, Gopinath
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5984717/
https://ncbi.nlm.nih.gov/pubmed/29610121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-17-1004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia